Skip to main content

Bristol-Myers Squibb to buy RayzeBio for $4.1B

By The Wall Street Journal  
   December 28, 2023

Deal demonstrates renewed interest in radiopharmaceutical drugs to treat cancer.

Full story


Get the latest on healthcare leadership in your inbox.